Sanket Koul, Prachi Pisal

All stories by Sanket Koul, Prachi Pisal

Abbott Bets On Semaglutide Boom
Rediff.com3 days ago

Abbott will exclusively distribute and market Extensior in the country, becoming the...

CDSCO allows immediate lab testing of drugs to speed up approvals
Rediff.com4 days ago

The Centre has allowed companies to begin lab testing immediately after filing...

Gurugram Dethrones Mumbai As India's Luxury Housing Capital
Rediff.com7 days ago

Gurugram has overtaken Mumbai to become India's biggest luxury housing market in 2025,...

Empty PG Seats, Missing Doctors
Rediff.com23 Feb 2026

'When young doctors see limited protection, unpredictable careers and an absence of...

HUL tops sustainability rankings as India Inc deepens ESG focus
Rediff.com19 Feb 2026

Hindustan Unilever (HUL) has topped the Perpetual Capital Hurun India Impact 50 - 2026...

Indian pharma to get stronger dose of EU mkt access
Rediff.com5 Feb 2026

The European Union's (EU's) offer to slash tariffs on 97.5 per cent of Indian chemical...

Realty to get indirect push from Budget proposals
Rediff.com3 Feb 2026

The government's Budget announcements providing tax holiday for data centres, setting...

Economic Syrvey flags India's siloed city governance model
Rediff.com31 Jan 2026

Through policy interventions, Indian cities need to be reimagined as a network of...

Under 40 Founders Power Rs 31 Trillion
Rediff.com30 Jan 2026

Interestingly, with 83 per cent of entrepreneurs being first-generation founders, the...

Centre mandates blue strip on antimicrobial drugs to curb overuse
Rediff.com24 Jan 2026

The Union health ministry has issued draft rules to mandate a blue vertical strip on...

Dr Reddy's profit down 14% on low Lenalidomide US sales
Rediff.com22 Jan 2026

Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y)...

NEET-PG Cutoff Cut Sparks Merit Debate
Rediff.com22 Jan 2026

'To fill these seats, eligibility is being diluted. We are compromising merit and...

Realty moves to the core of conglomerates' biz strategy
Rediff.com21 Jan 2026

India's leading conglomerates are stepping up investments in real estate, recasting...

Ageing CBD offices emerge as developers' next growth play
Rediff.com13 Jan 2026

Office redevelopment is emerging as a key growth frontier for developers as India's...

Govt Bans Sale Of Oral Nimesulide
Rediff.com2 Jan 2026

The Union health ministry has banned the manufacture, sale and distribution of all oral...

At 150k, Mumbai logs highest property registrations in 14 yrs in 2025
Rediff.com1 Jan 2026

Mumbai recorded its strongest housing market performance in 14 years in 2025, with...

Centre Proposes Stricter Cough Syrup Rules
Rediff.com1 Jan 2026

Following the death of 22 children due to consumption of contaminated cough syrups in...

Why non- NCR developers are flocking to Gurugram
Rediff.com30 Dec 2025

Gurugram, already established as the corporate hub of Delhi-NCR, is increasingly...

Realty faces execution pressure as developers expand launch pipelines
Rediff.com22 Dec 2025

Developers are entering one of the busiest construction cycles, with the top four firms...

Weightloss Drugs Hit 1,000 Crore Mark
Rediff.com22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and...